Financial Results

Key highlights

Filter

Period

Filter by

recent search

Showing: 1 – 05 of 22 Financial Results

Ipsen delivers solid H1 2023 results and upgrades its full-year guidance
Ipsen delivers solid H1 2023 results and upgrades its full-year guidance

The performance in the first half of the year is reflected in today’s upgrade to our full-year guidance. We look forward to more milestones and further expansion of the pipeline over time through additional external-innovation transactions. I am confident, as…





Ipsen delivers strong H1 2022 results and upgrades its full-year guidance
Ipsen delivers strong H1 2022 results and upgrades its full-year guidance

Paris (France), 28 July 2022 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical company, presents its financial results for the first half of 2022:


1 2 3 4 5

Your dedicated contacts